Haloperidol decanoate and Lantus solostar drug interactions - a phase IV clinical study of FDA data
Summary:
We study 43,529 people who take Haloperidol decanoate (haloperidol decanoate) and Lantus solostar (insulin glargine recombinant). There is no drug interaction reported.
The study analyzes what interactions people have when they take Haloperidol decanoate and Lantus solostar. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Haloperidol decanoate?
Haloperidol decanoate has active ingredients of haloperidol decanoate. eHealthMe is studying from 1,890 Haloperidol decanoate users. Check the latest studies of Haloperidol decanoate.
What is Lantus solostar?
Lantus solostar has active ingredients of insulin glargine recombinant. It is often used in diabetes. eHealthMe is studying from 41,639 Lantus solostar users. Check the latest studies of Lantus solostar.
No report is found.
Do you take Haloperidol decanoate and Lantus solostar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Haloperidol decanoate (1,890 reports)
- Lantus solostar (41,639 reports)
How the study uses the data?
The study uses data from the FDA. It is based on haloperidol decanoate and insulin glargine recombinant (the active ingredients of Haloperidol decanoate and Lantus solostar, respectively), and Haloperidol decanoate and Lantus solostar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lamisil cause Liver Disorder? - 4 seconds ago
- Could Atenolol cause Eating Disorder? - 5 seconds ago
- Could Pantoprazole Sodium cause Injection Site Erythema? - 10 seconds ago
- Could Lortab cause Allergic Rhinitis? - 11 seconds ago
- Drug interactions of Indomethacin and Cyclophosphamide - 12 seconds ago
- Could Morphine cause Postoperative Wound Complication? - 13 seconds ago
- Drug interactions of Levaquin and Trasylol - 13 seconds ago
- Could Latanoprost cause Dysphagia Aggravated? - 14 seconds ago
- Could Avalide cause Breast Cancer? - 14 seconds ago
- Drug interactions of Theophylline and Carboplatin - 15 seconds ago